Leading immuno-oncology company adopts Genedata Biologics to support the discovery and development of TCRs for adoptive cell therapies and bispecific TCR molecules Basel, Switzerland Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that Immatics Biotechnologies, a clinical-stage biopharmaceutical company developing T-cell receptor (TCR)-based cancer immunotherapies, has adopted Genedata Biologics® to streamline their R&D […]
Nanopore sequencing can now be used for investigating chromatin contacts, to identify genome-wide contacts directly, without amplification. Weill Cornell Medicine and Oxford Nanopore have published a pre-print describing this new technique, and an end-to-end workflow and analysis tools are now available online. Investigating genome architecture Chromatin structure relies on the physical interaction of many genomic loci and investigating the architecture of […]
Agilent Technologies Inc. (NYSE: A) and MGI Tech have signed an agreement to conduct more in-depth cooperation in high throughput sequencing, which will give full play to their respective advantages in laboratory information management and sequencing platforms and provide the industry with a more efficient and reliable high throughput sequencing overall solution. Recently, at the […]
* ORFLO’s cell analysis offering to complement Gemini’s portfolio of cell culture reagents WEST SACRAMENTO, CA – Gemini Bioproducts, LLC (“Gemini”), a leading provider of cell culture solutions and a portfolio company of BelHealth Investment Partners, LLC (“BelHealth”), today announced the acquisition of ORFLO Technologies (“ORFLO”), an innovative life sciences instrumentation company. Founded in 2003 […]
Lakewood, CO, USA: Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”), a diversified supplier of quality control instruments and consumables to highly regulated markets today announced the acquisition of Gyros Protein Technologies Holding AB (“GPT”). GPT is headquartered in Uppsala, Sweden and is a leading provider of Immunoassay and Peptide Synthesis solutions that […]
Conference call to be held today, 11November 2019, 11 a.m. CET/10 a.m. GMT Heidelberg, Germany and Cambridge – Expedeon AG (Frankfurt: EXNN; ISIN: DE000A2YN801; Prime Standard) announces the signing of an agreement with Abcam plc (London Stock Exchange: ABC; ISIN: GB00B6774699; AIM MTF), Cambridge, UK, to sell its proteomics and immunology business activities for a […]
Animal model operations to be transferred to Envigo ownership Divestment in line with Horizon’s corporate strategy to focus on its core markets Envigo, a leading global research model supplier, enters the gene-edited research model field with the addition of Horizon’s business Horizon and Envigo to collaborate on providing CRISPR screening services Cambridge, UK, 08 November 2019: Horizon […]
BrickBio’s technology enables efficient placement of unnatural amino acids into recombinant antibodies at specific sites Together, the organizations will industrialize the technology to serve both the research and diagnostic markets CAMBRIDGE, UK and BOSTON, MA, USA — Abcam plc, a global innovator in life science reagents and tools, is today pleased to announce a strategic partnership […]
Appointment follows resignation of Director Dr. Charles Ryan STONY BROOK, N.Y. – Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”) a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing for product authenticity, traceability solutions and nucleic acid-based biotherapeutic research, today announced the appointment of Scott L. Anchin to its Board of Directors following the resignation […]
Twist Biopharma Implements Genedata Biologics to Advance Synthetic Biology-driven Antibody Discovery
First-in-class software platform digitalizes Twist Biopharma’s innovative antibody lead identification and optimization SAN FRANCISCO–Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that Twist Biopharma, a division of Twist Bioscience (NASDAQ: TWST), has adopted Genedata Biologics® to support their R&D innovation for biologics drug discovery services. In addition, Twist will use the […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
